Collagen Market Growth Accelerates as BASF Introduces Advanced Precision Peptides

NeoHelix Regenerate and SkinNexus Collag3n, two novel cosmetic active ingredients designed to further skin rejuvenation and collagen preservation technologies, were introduced by BASF. The new ingredients, which were introduced at In-Cosmetics Global 2026 in Paris, are part of BASF's most recent initiatives to meet the rising demand from customers for cutting-edge anti-aging and skin-health products. The launch demonstrates the company's dedication to creating next-generation personal care ingredients by fusing biotechnology and precise science. Furthermore, it is anticipated that these developments would improve BASF's standing in the quickly growing collagen-based cosmetics market.

Advancing Precision Collagen Renewal and Collagen Banking

NeoHelix Regenerate is a high-performance precise peptide that supports adaptive collagen renewal and strengthens the skin's natural self-healing processes. The chemical is positioned as a breakthrough in anti-aging skincare after clinical studies showed notable improvements in skin tonicity, wrinkle appearance, and collagen restoration. In the meantime, long-term collagen preservation, or collagen banking, is supported by SkinNexus Collag3n, a recombinant bio-identical collagen III fragment made using vegan yeast fermentation. The component supported full-spectrum collagen homeostasis and showed quantifiable benefits in skin firmness, sagging, and fine wrinkles. Additionally, BASF created these solutions by working with biotechnology firms at 3Helix and Bota Biosciences, utilizing cutting-edge bioengineering and AI-powered biomanufacturing technologies.

“Both ingredients are impressive examples of the innovative power that strong partnerships can unleash. By working with the skin's own biology, we are moving from traditional collagen support claims to more advanced renewal and preservation across multiple levels,” said Lucilene Veira Nunes, business management, BASF Beauty Care Solutions.

According to Precedence Research, the collagen market size was estimated at USD 12.24 billion in 2025 and is projected to grow from USD 13.22 billion in 2026 to approximately USD 29.66 billion by 2035, expanding at a CAGR of 9.25% from 2026 to 2035, driven by increasing consumer demand for beauty-from-within products, rising adoption of nutraceutical supplements, and growing applications of collagen in cosmetics and healthcare.

Industry Impact and Market Outlook

The introduction of NeoHelix Regenrate and SkinNexus Collag3n is indicative of the collagen market's increasing integration of biotechnology, AI, and customized skincare. Manufacturers are making significant investments in bioengineered and precision-based collagen technologies as consumers seek out more sustainable and scientifically proven cosmetic solutions. High-performance collagen compounds are anticipated to become more widely used in cosmetic and personal care formulations due to these developments. Furthermore, the collagen industry’s growing use of AI-enabled biomanufacturing platforms is probably going to change how products are developed in the future and improve scalability. It is anticipated that BASF's most recent developments will propel other developments in high-end skincare products and sustain long-term expansion in the worldwide collagen market.